Search Results - "Graham, Richard T."

Refine Results
  1. 1
  2. 2

    Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201 by Xin, Dazhuan Eric, Liao, Yunfei, Rao, Rohit, Ogurek, Sean, Sengupta, Soma, Xin, Mei, Bayat, Arman Esshaghi, Seibel, William L, Graham, Richard T, Koschmann, Carl, Lu, Q Richard

    Published in Neuro-oncology (Charlottesville, Va.) (05-04-2024)
    “…Diffuse intrinsic pontine gliomas (DIPG/DMG) are devastating pediatric brain tumors with extraordinarily limited treatment options and uniformly fatal…”
    Get full text
    Journal Article
  3. 3

    Venous thromboembolism in children with central nervous system tumors: Comparison of an institutional cohort to a national administrative database by Graham, Richard T., Coven, Scott L., Stanek, Joseph R., Folta, Ashley, Hollingsworth, Ethan W., Finlay, Jonathan L., Kumar, Riten

    Published in Pediatric blood & cancer (01-03-2021)
    “…Background Central nervous system (CNS) tumors are the second most common malignancy of childhood, and published data on venous thromboembolism (VTE) rate and…”
    Get full text
    Journal Article
  4. 4

    Multi‐institutional analysis of central nervous system germ cell tumors in patients with Down syndrome by Harris, Micah K., Graham, Richard T., Cappellano, Andréa M., Margol, Ashley S., Michaiel, George, Crawford, John R., Ioakeim‐Ioannidou, Myrsini, Stanek, Joseph R., Liu, Kevin X., MacDonald, Shannon M., Abdelbaki, Mohamed S.

    Published in Pediatric blood & cancer (01-10-2022)
    “…Purpose Primary germ cell tumors (GCTs) are the most common central nervous system (CNS) neoplasm in patients with Down syndrome (DS). However, a standard of…”
    Get full text
    Journal Article
  5. 5

    Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors by Abu‐Arja, Mohammad H., Osorio, Diana S., Lassaletta, Alvaro, Graham, Richard T., Coven, Scott L., Stanek, Joseph R., Bouffet, Eric, Finlay, Jonathan L., Abdelbaki, Mohamed S.

    Published in Pediatric blood & cancer (01-01-2022)
    “…We aimed toidentify prognostic factors that may help better understand the behavior of relapsed central nervous system nongerminomatous germ cell tumors. We…”
    Get full text
    Journal Article
  6. 6

    Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients by Graham, Richard T., Bell, Erica H., Webb, Amy, Zhao, Yue, Timmers, Cynthia, Fleming, Jessica L., Sells, Blake E., Robison, Nathan J., Palmer, Joshua D., Finlay, Jonathan L., Chakravarti, Arnab

    Published in Journal of pediatric hematology/oncology (01-11-2021)
    “…Gliosarcoma is rare among pediatric patients and among individuals with Neurofibromatosis Type 1 (NF1). Here we compare 2 pediatric gliosarcoma patients, one…”
    Get full text
    Journal Article
  7. 7
  8. 8

    QOL-23. Expanded protocols for hearing loss related cisplatin-based therapy in childhood cancer patients by Grosnik, Amy, Graham, Richard T, Pillay-Smiley, Natasha, de Blank, Peter, Hummel, Trent, Mochizuki, Aaron, Raskin, Scott, Windmill, Ian

    Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)
    “…Abstract BACKGROUND: Most children who require cisplatin chemotherapy incur hearing loss. The basal end of the cochlea, corresponding to high frequency sound…”
    Get full text
    Journal Article
  9. 9

    BIOL-05. IDENTIFICATION AND VALIDATION OF PA2G4 AS A POTENTIAL THERAPEUTIC TARGET IN PEDIATRIC DIFFUSE GLIOMAS by Sirhan, Zaid, Sells, Blake E, Fleming, Jessica, Manring, Heather R, Graham, Richard T, McElroy, Joseph P, Haque, Saikh J, Boué, Daniel R, Becker, Aline P, Bell, Erica H, Finlay, Jonathan, Chakravarti, Arnab

    Published in Neuro-oncology (Charlottesville, Va.) (12-06-2023)
    “…Abstract Brain tumors are the second most common pediatric malignancy after leukemia. High grade gliomas have a significantly high morbidity and mortality in…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    PATH-15. PROTEOMIC SIGNATURES PREDICT GRADE IN PEDIATRIC AND YOUNG ADULT INFILTRATIVE ASTROCYTOMAS by Graham, Richard T, Sells, Blake E, Fleming, Jessica, McElroy, Joseph P, Bell, Erica H, Haque, S Jaharul, Becker, Aline P, Boué, Daniel R, Finlay, Jonathan L, Chakravarti, Arnab

    Published in Neuro-oncology (Charlottesville, Va.) (04-12-2020)
    “…Abstract BACKGROUND Infiltrative astrocytomas in children and young adults pose a treatment challenge due to the difficulty of achieving gross total resection…”
    Get full text
    Journal Article
  14. 14

    MBCL-06. SUCCESSFUL SALVAGE OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA PATIENTS TREATED ON ACNS1221 by Graham, Richard T, Conley, Suzanne, Finlay, Jonathan L, AbdelBaki, Mohamed S

    Published in Neuro-oncology (Charlottesville, Va.) (22-06-2018)
    “…Abstract Desmoplastic nodular medulloblastoma (DNMB) is among the most treatable pediatric brain tumors with overall survival often reported in the range of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    HGG-30. PEDIATRIC GLIOSARCOMA WITH AND WITHOUT NEUROFIBROMATOSIS TYPE 1: A WHOLE-EXOME COMPARISON OF TWO PATIENTS by Graham, Richard T, Bell, Erica Hlavin, Webb, Amy, Timmers, Cynthia, Robison, Nathan, Palmer, Joshua, Finlay, Jonathan L, Chakravarti, Arnab

    Published in Neuro-oncology (Charlottesville, Va.) (22-06-2018)
    “…Abstract BACKGROUND/OBJECTIVE Gliosarcoma is a WHO grade IV histologic variant of glioblastoma that occurs very rarely among pediatric patients, even more so…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20